Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 250-251

  Sánchez Castañeda, Cristina ^a   Campdelacreu, Jaume ^a   Miró, Júlia ^a   Juncadella, Montse ^a   Jaumà, Serge ^a   Calopa, Màtil ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CABERGOLINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; RIVASTIGMINE;

AGED; AKINESIA; CASE REPORT; COGNITIVE DEFECT; CONFUSION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DYSKINESIA; EVENING DOSAGE; FEMALE; HUMAN; INSOMNIA; LETTER; MALE; MINI MENTAL STATE EXAMINATION; MORNING DOSAGE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PSYCHOSIS; SYMPTOMATOLOGY;

AGED; ANTIPARKINSON AGENTS; COGNITION DISORDERS; DUODENUM; FEMALE; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE;

EID: 73649103696     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.10.021     Document Type: Letter

References (7)

1. Cools R., Stefanova E., Barker R.A., Robbins T.W., and Owen A.M. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125 Pt 3 (2002) 584-594
2. Devos D. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord 24 7 (2009) 993-1000
3. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22 12 (2007) 1689-1707
4. Fera F., Nicoletti G., Cerasa A., Romeo N., Gallo O., Gioia M.C., et al. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain Res Bull 74 1-3 (2007) 75-83
5. Kulisevsky J., García-Sánchez C., Berthier M.L., Barbanoj M., Pascual-Sedano B., Gironell A., et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord 15 4 (2000) 613-626
6. Nyholm D., Lewander T., Johansson A., Lewitt P.A., Lundqvist C., and Aquilonius S.M. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure. Clin Neuropharmacol 31 2 (2008) 63-73
7. Witjas T., Kaphan E., Régis J., Jouve E., Chérif A.A., Péragut J.C., et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 22 (2007) 1729-1934